These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8733895)

  • 1. Effect of cilostazol on the production of platelet-derived growth factor in cultured human vascular endothelial cells.
    Mizutani M; Okuda Y; Yamashita K
    Biochem Mol Med; 1996 Apr; 57(2):156-8. PubMed ID: 8733895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High glucose increases platelet-derived growth factor production in cultured human vascular endothelial cells and preventive effects of eicosapentaenoic acids.
    Mizutani M; Okuda Y; Suzuki S; Sawada T; Soma M; Yamashita K
    Life Sci; 1995; 57(2):PL31-5. PubMed ID: 7603290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased production of PDGF by angiotensin and high glucose in human vascular endothelium.
    Okuda Y; Adrogue HJ; Nakajima T; Mizutani M; Asano M; Tachi Y; Suzuki S; Yamashita K
    Life Sci; 1996; 59(17):1455-61. PubMed ID: 8890924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cilostazol inhibits cytokine-induced nuclear factor-kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells.
    Hattori Y; Suzuki K; Tomizawa A; Hirama N; Okayasu T; Hattori S; Satoh H; Akimoto K; Kasai K
    Cardiovasc Res; 2009 Jan; 81(1):133-9. PubMed ID: 18703532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High glucose and hyperosmolarity increase platelet-derived growth factor mRNA levels in cultured human vascular endothelial cells.
    Mizutani M; Okuda Y; Yamaoka T; Tsukahara K; Isaka M; Bannai C; Yamashita K
    Biochem Biophys Res Commun; 1992 Sep; 187(2):664-9. PubMed ID: 1530624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of neointimal formation after balloon injury by cilostazol, accompanied by improvement of endothelial dysfunction and induction of hepatocyte growth factor in rat diabetes model.
    Aoki M; Morishita R; Hayashi S; Jo N; Matsumoto K; Nakamura T; Kaneda Y; Ogihara T
    Diabetologia; 2001 Aug; 44(8):1034-42. PubMed ID: 11484082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of hepatocyte growth factor in endothelial regulation: prevention of high D-glucose-induced endothelial cell death by prostaglandins and phosphodiesterase type 3 inhibitor.
    Morishita R; Higaki J; Hayashi SI; Yo Y; Aoki M; Nakamura S; Moriguchi A; Matsushita H; Matsumoto K; Nakamura T; Ogihara T
    Diabetologia; 1997 Sep; 40(9):1053-61. PubMed ID: 9300242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cilostazol, a cAMP phosphodiesterase inhibitor, attenuates the production of monocyte chemoattractant protein-1 in response to tumor necrosis factor-alpha in vascular endothelial cells.
    Nishio Y; Kashiwagi A; Takahara N; Hidaka H; Kikkawa R
    Horm Metab Res; 1997 Oct; 29(10):491-5. PubMed ID: 9405974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cilostazol activates AMP-activated protein kinase and restores endothelial function in diabetes.
    Suzuki K; Uchida K; Nakanishi N; Hattori Y
    Am J Hypertens; 2008 Apr; 21(4):451-7. PubMed ID: 18369362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cilostazol inhibits cytokine-induced tetrahydrobiopterin biosynthesis in human umbilical vein endothelial cells.
    Shiraishi H; Ikemoto K; Tada S; Udagawa Y; Ohtsuki M; Sumi-Ichinose C; Kondo K; Nomura T
    J Atheroscler Thromb; 2011; 18(4):312-7. PubMed ID: 21224523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of anti-platelet aggregating activity of cilostazol with vascular endothelial cells.
    Igawa T; Tani T; Chijiwa T; Shiragiku T; Shimidzu S; Kawamura K; Kato S; Unemi F; Kimura Y
    Thromb Res; 1990 Feb; 57(4):617-23. PubMed ID: 2158154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cilostazol inhibits monocytic cell adhesion to vascular endothelium via upregulation of cAMP.
    Mori D; Ishii H; Kojima C; Nitta N; Nakajima K; Yoshida M
    J Atheroscler Thromb; 2007 Oct; 14(5):213-8. PubMed ID: 17938542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cilostazol inhibits high glucose-mediated endothelial-neutrophil adhesion by decreasing adhesion molecule expression via NO production.
    Omi H; Okayama N; Shimizu M; Fukutomi T; Nakamura A; Imaeda K; Okouchi M; Itoh M
    Microvasc Res; 2004 Sep; 68(2):119-25. PubMed ID: 15313121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic AMP inhibited proliferation of human aortic vascular smooth muscle cells, accompanied by induction of p53 and p21.
    Hayashi S; Morishita R; Matsushita H; Nakagami H; Taniyama Y; Nakamura T; Aoki M; Yamamoto K; Higaki J; Ogihara T
    Hypertension; 2000 Jan; 35(1 Pt 2):237-43. PubMed ID: 10642304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endotoxin stimulates platelet-derived growth factor production from cultured human pulmonary endothelial cells.
    Albelda SM; Elias JA; Levine EM; Kern JA
    Am J Physiol; 1989 Aug; 257(2 Pt 1):L65-70. PubMed ID: 2764117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-derived growth factor production by human umbilical vein endothelial cells is regulated by basic fibroblast growth factor.
    Kourembanas S; Faller DV
    J Biol Chem; 1989 Mar; 264(8):4456-9. PubMed ID: 2925652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone Morphogenic Protein 4-Smad-Induced Upregulation of Platelet-Derived Growth Factor AA Impairs Endothelial Function.
    Hu W; Zhang Y; Wang L; Lau CW; Xu J; Luo JY; Gou L; Yao X; Chen ZY; Ma RC; Tian XY; Huang Y
    Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):553-60. PubMed ID: 26769046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of lipopolysaccharide-induced apoptosis by cilostazol in human umbilical vein endothelial cells.
    Kim KY; Shin HK; Choi JM; Hong KW
    J Pharmacol Exp Ther; 2002 Feb; 300(2):709-15. PubMed ID: 11805237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenoviral delivery of a leukocyte-type 12 lipoxygenase ribozyme inhibits effects of glucose and platelet-derived growth factor in vascular endothelial and smooth muscle cells.
    Patricia MK; Natarajan R; Dooley AN; Hernandez F; Gu JL; Berliner JA; Rossi JJ; Nadler JL; Meidell RS; Hedrick CC
    Circ Res; 2001 Apr; 88(7):659-65. PubMed ID: 11304487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 15-Deoxy-prostaglandin J(2) inhibits PDGF-A and -B chain expression in human vascular endothelial cells independent of PPAR gamma.
    Zhang J; Fu M; Zhao L; Chen YE
    Biochem Biophys Res Commun; 2002 Oct; 298(1):128-32. PubMed ID: 12379230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.